StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BioMarin Pharma (BMRN) FDA briefing docs released
November 20, 2015 7:59 AM
BioMarin Pharma (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Trader Talk
Next Articles
FDA Briefing Docs Offer Positives and Negatives for Sarepta (SRPT) - Baird
November 23, 2015 6:55 AM
Concerns on Drisapersen Positive for Sarepta's (SRPT) Eteplirsen - Needham & Company
November 20, 2015 11:19 AM
Despite Harsh BioMarin (BMRN) Briefing Docs, the Jury is Still Out - Leerink Partners
November 20, 2015 10:21 AM
BioMarin (BMRN) Has Good Risk/Reward Despite Cautious FDA Briefing Documents for Drisapersen, Says RBC
November 20, 2015 10:12 AM
BioMarin Pharma (BMRN) Briefing Docs 'Ugly' - Baird (SRPT)
November 20, 2015 9:50 AM
Sarepta Therapeutics (SRPT) Surges 25% Following BioMarin (BMRN) Briefing Docs
November 20, 2015 8:36 AM
BioMarin Pharma (BMRN) Announces Consistent Drisapersen Efficacy Evidence Demonstrated Across Three Studies
November 20, 2015 8:12 AM
BioMarin Pharma (BMRN) Affirms Posting of Drisapersen NDA Briefing Docs
November 20, 2015 8:11 AM
Baird Expects FDA Rejection for Drisapersen and Eteplirsen (BMRN) (SRPT)
November 19, 2015 8:18 AM
Jefferies Survey Suggests Positive Expectations for BioMarin (BMRN) Ahead of Data on 11/24
November 19, 2015 7:42 AM
